Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamoto, E.
Right arrow Articles by Katoh, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamoto, E.
Right arrow Articles by Katoh, H.
Clinical Cancer Research Vol. 10, 3629-3638, June 1, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Gene-Expression Profile Changes Correlated with Tumor Progression and Lymph Node Metastasis in Esophageal Cancer

Eiji Tamoto1, Mitsuhiro Tada3, Katsuhiko Murakawa1, Minoru Takada1, Gaku Shindo1, Ken-ichi Teramoto1, Akihiro Matsunaga1, Kazuteru Komuro1, Motoshi Kanai1, Akiko Kawakami4, Yoshie Fujiwara4, Nozomi Kobayashi4, Katsutoshi Shirata4, Norihiro Nishimura4, Shun-ichi Okushiba1, Satoshi Kondo1, Jun-ichi Hamada3, Takashi Yoshiki2, Tetsuya Moriuchi3 and Hiroyuki Katoh1

1 Department of Surgical Oncology, Division of Cancer Medicine, Graduate School of Medicine, 2 Department of Pathology/Pathophysiology, Division of Pathophysiological Science, and 3 Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, and 4 GeneticLab Co., Ltd., Sapporo, Japan

ABSTRACT

Purpose: The purpose of this research was to identify molecular clues to tumor progression and lymph node metastasis in esophageal cancer and to test their value as predictive markers.

Experimental Design: We explored the gene expression profiles in cDNA array data of a 36-tissue training set of esophageal squamous cell carcinoma (ESCC) by using generalized linear model-based regression analysis and a feature subset selection algorithm. By applying the identified optimal feature sets (predictive gene sets), we trained and developed ensemble classifiers consisting of multiple probabilistic neural networks combined with AdaBoosting to predict tumor stages and lymph node metastasis. We validated the classifier abilities with 18 independent cases of ESCC.

Results: We identified 71 genes of 1289 cancer-related genes of which the expression correlated with tumor stages. Of the 71 genes, 47 significantly differed between the Tumor-Node-Metastasis pT1/2 and pT3/4 stages. Cell cycle regulators and transcriptional factors possibly promoting the growth of tumor cells were highly expressed in the early stages of ESCC, whereas adhesion molecules and extracellular matrix-related molecules possibly promoting invasiveness increased in the later stages. For lymph node metastasis, we identified 44 genes with predictive values, which included cell adhesion molecules and cell membrane receptors showing higher expression in node-positive cases and cell cycle regulators and intracellular signaling molecules showing higher expression in node-negative cases. The ensemble classifiers trained with the selected features predicted tumor stage and lymph node metastasis in the 18 validation cases with respective accuracies of 94.4% and 88.9%. This demonstrated the reproducibility and predictive value of the identified features.

Conclusion: We suggest that these characteristic genes will provide useful information for understanding the malignant nature of ESCC as well as information useful for personalizing the treatments.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
S. M. Lagarde, P. E. Ver Loren van Themaat, P. D. Moerland, L. A. Gilhuijs-Pederson, F. J. W. ten Kate, P. H. Reitsma, A. H. C. van Kampen, A. H. Zwinderman, F. Baas, and J. J. B. van Lanschot
Analysis of Gene Expression Identifies Differentially Expressed Genes and Pathways Associated with Lymphatic Dissemination in Patients with Adenocarcinoma of the Esophagus
Ann. Surg. Oncol., December 1, 2008; 15(12): 3459 - 3470.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Ishikawa, A. Takano, W. Yasui, K. Inai, H. Nishimura, H. Ito, Y. Miyagi, H. Nakayama, M. Fujita, M. Hosokawa, et al.
Cancer-Testis Antigen Lymphocyte Antigen 6 Complex Locus K Is a Serologic Biomarker and a Therapeutic Target for Lung and Esophageal Carcinomas
Cancer Res., December 15, 2007; 67(24): 11601 - 11611.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yamabuki, A. Takano, S. Hayama, N. Ishikawa, T. Kato, M. Miyamoto, T. Ito, H. Ito, Y. Miyagi, H. Nakayama, et al.
Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas
Cancer Res., March 15, 2007; 67(6): 2517 - 2525.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.